Risperidone reduction of amphetamine-induced self-injurious behavior in mice

Area of Science:

• Neuroscience
• Pharmacology
• Behavioral Science

Background:

• Amphetamine administration can induce complex behavioral changes.
• Understanding the neurochemical underpinnings of drug-induced behaviors is crucial.
• Dopamine and serotonin pathways are implicated in various behavioral responses.

Purpose of the Study:

• To investigate the behavioral and neurochemical effects of high-dose amphetamine in mice.
• To examine the role of dopamine (D1, D2) and serotonin receptors in amphetamine-induced behaviors.
• To evaluate the efficacy of specific antagonists in modulating these effects.

Main Methods:

• BALB/c mice were administered high doses of amphetamine.
• Co-administration of haloperidol (D2 antagonist), SCH 23390 (D1 antagonist), and risperidone (5-HT2/D2 antagonist) was performed.
• Behavioral assessments included stereotypic behavior, oral dyskinesia, and self-injurious behavior (SIB).
• Neurochemical analysis focused on serotonin release, with motor activity and hyperthermia as controls.

Main Results:

• Amphetamine induced a dose-dependent increase in stereotypic behavior, oral dyskinesia, and SIB.
• Antagonists that blocked SIB also reversed amphetamine-induced serotonin release.
• These behavioral changes were independent of hyperthermia or sedation.

Conclusions:

• Murine SIB involves both dopaminergic and serotonergic activation.
• The findings highlight the complex interplay between neurotransmitter systems in drug-induced behaviors.
• Risperidone demonstrated efficacy in treating amphetamine-induced SIB, suggesting its therapeutic potential.